{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002418","experiment":{"EXPERIMENT_TYPE":"Histone H3K27ac","EXPERIMENT_ID":"EGAX00001379547","attributes":{"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["\"4 min; 30 sec ON/ 30 sec OFF\""],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"CHIP_ANTIBODY":["H3K27ac"],"EXPERIMENT_TYPE":["Histone H3K27ac"],"CHIP_ANTIBODY_CATALOG":["BP grade"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 ul"],"CHIP_ANTIBODY_LOT":["A1723-0041d"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 ug"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["1x 500.000 cells = 33 ul"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked 10 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Protocol July 2014: 500.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["185"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Pico (UCD-600)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/S01BRZ/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigWig","SIZE":"1016M","NAME":"S01BRZH1.ERX1384813.H3K27ac.bwa.GRCh38.20160324.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/S01BRZ/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01BRZH1.ERX1384813.H3K27ac.bwa.GRCh38.20160324.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"5abe2bd3bb936b5a30d39a0e5c01ec7a"},{"FORMAT":"bigBed","SIZE":"2.9M","NAME":"S01BRZH1.ERX1384813.H3K27ac.bwa.GRCh38.20160721.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/S01BRZ/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01BRZH1.ERX1384813.H3K27ac.bwa.GRCh38.20160721.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"8569a54ab06b431cbb61cce63efb11d5"},{"FORMAT":"BED","SIZE":"3.2M","NAME":"S01BRZH1.ERX1384813.H3K27ac.bwa.GRCh38.20160721.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/S01BRZ/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01BRZH1.ERX1384813.H3K27ac.bwa.GRCh38.20160721.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"5b5c8eb2bc3f380c4fa3e73759675d76"},{"FORMAT":"Text","SIZE":"3.7M","NAME":"S01BRZH1.ERX1384813.H3K27ac.bwa.GRCh38.20160721.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/S01BRZ/Acute_Myeloid_Leukemia/ChIP-Seq/NCMLS/S01BRZH1.ERX1384813.H3K27ac.bwa.GRCh38.20160721.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"0ae9957ef2b93fea82d2dd5be8dea29c"}],"dataset_id":"EGAD00001002418","sample":{"SAMPLE_SOURCE":"bone marrow","SAMPLE_NAME":"S01BRZ","sample_barcode":"S01BRZH1","attributes":{"MARKERS":["CD34"],"DONOR_HEALTH_STATUS":["Acute Myeloid Leukemia"],"DONOR_AGE":["70 - 75"],"MOLECULE":["genomic DNA"],"DISEASE":["Acute Myeloid Leukemia"],"BIOMATERIAL_PROVIDER":["Prof.dr. E. Vellenga, University Medical Centre Groningen - Department of Hematology"],"CELL_TYPE":["myeloid cell"],"BIOMATERIAL_TYPE":["Primary Cell"],"TISSUE_TYPE":["bone marrow"],"DISEASE_ONTOLOGY_URI":[{"url":"7","label":"C0023467"}],"SAMPLE_ONTOLOGY_URI":[{"url":"3","label":"CL_0000763"}],"GENDER":["female"],"DONOR_ID":["S01BRZ"],"DONOR_SEX":["Female"],"DONOR_ETHNICITY":["Caucasian"]},"SAMPLE_ID":"EGAN00001374924","SAMPLE_DESCRIPTION":"Acute Myeloid Leukemia"}}